logo

[EB] Pericardial effusion with tamponade

Published: 2026-01-31

<figure class="table" style="width:100%;"><table class="ck-table-resized"><colgroup><col style="width:71.63%;"><col style="width:28.37%;"></colgroup><tbody><tr><td><figure class="image"><img style="aspect-ratio:761/427;" src="/api/download/dllFZ1lRNTQwcXZhOWJmVnVYV1lKSURjcmFKT2IvUkVSa29vck01V3BDaURYS0ZjMi9ZN1ZGVmwrc3MxTkRMVjYyTHkwc09DZldnSjZSZzFRaWdvY3c9PQ" width="761" height="427"></figure></td><td><figure class="image"><img style="aspect-ratio:421/808;" src="/api/download/dllFZ1lRNTQwcXZhOWJmVnVYV1lKTm5HUnFkRkZJbFpqNmVEaWVZdEg4eGJaREVkOVZkUER3c1diMnh0OUR5ODI3aE1IOWQybjNPWkpuT3kvSXhGUGc9PQ" width="421" height="808"></figure></td></tr></tbody></table></figure><p>Check out elevated “Critical” and “PrcEff” Biomarker. The combined elevation of both of the biomarker suggests increased risk of cardiac tamponade.<br>&nbsp;</p><p>ECG Source:</p><p>https://wikem.org/wiki/Pericardial_effusion_and_tamponade</p>

Read more

logo

ARPI, IncCEO: Joonghee Kim

TEL : 031-738-0110EMAIL : [email protected]

Kins Tower Suite 1401, 8 Seongnam-daero 331beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea

Privacy PolicyTerms of Service

Copyright 2026 ARPI All Right Reserved.

  • About ARPI

    • Company
    • Milestones
    • Partners
  • Products

    • ECG Buddy
    • ECG Buddy_LVD
    • ECG Buddy Clinic
  • Resources

    • User Manual
    • EMS
    • Publications
    • FAQ
    • Case Library
  • News & Media

    • PR
    • Events
    • Blog
  • Contact us

    • Request
  • sns
  • sns
contact